- Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
-
Kwok SK
- KMID: 1794621
- Korean J Intern Med.
- 2014 Sep;29(5):577-579.
- doi: 10.3904/kjim.2014.29.5.577
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
-
Kim JW, Choi IA, Lee EY, Song YW, Lee EB
- KMID: 1793016
- J Korean Med Sci.
- 2013 Aug;28(8):1134-1138.
- doi: 10.3346/jkms.2013.28.8.1134
Tofacitinib, a novel Janus kinase inhibitor, may prevent structural damage in rheumatoid arthritis (RA). In this cohort study, we compared radiographic progression of hand joints between 21 RA patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Dynamic Contrast-Enhanced MRI for Monitoring Antiangiogenic Treatment: Determination of Accurate and Reliable Perfusion Parameters in a Longitudinal Study of a Mouse Xenograft Model
-
Song Y, Cho G, Suh JY, Lee CK, Kim YR, Kim YJ, Kim JK
- KMID: 1715763
- Korean J Radiol.
- 2013 Aug;14(4):589-596.
- doi: 10.3348/kjr.2013.14.4.589
OBJECTIVE: To determine the reliable perfusion parameters in dynamic contrast-enhanced MRI (DCE-MRI) for the monitoring antiangiogenic treatment in mice. MATERIALS AND METHODS: Mice, with U-118 MG tumor, were treated with either... -
- CITED
-
- Close
- SHARE
-
- Close
